Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Bullboard Posts
Comment by JordanDeeon May 02, 2017 2:08am
176 Views
Post# 26190595

RE:Ventripoints MD&A and Financials....

RE:Ventripoints MD&A and Financials....Awesome find! I'm a little unclear about something though. In the MD&A it states, "YuTian has applied to the C-FDA for approval of the VMS-PLUS with RV analysis software and expects to have marketing approval in 2017. The other two machines will be used to demonstrate the machine to leading cardiologists and distributors in China. Our Chinese partners are establishing a distribution network for medical devices for all of China". If this the case,why wouldn't they have released a statement about applying for C-FDA approval? Also, it says they applied for the VMS PLUS with RV analysis, yet they have an analysis for all four chambers? Great info, but I'm not sure why they have not released the application for C-FDA approval. JordanDee
Bullboard Posts